Murine Gamma Herpesvirus 68 Hijacks MAVS and IKKβ to Abrogate NFκB Activation and Antiviral Cytokine Production
Upon viral infection, mitochondrial antiviral signaling (MAVS) protein serves as a key adaptor to promote cytokine production. We report here that murine gamma herpesvirus 68 (γHV68), a model virus for oncogenic human gamma herpesviruses, subverts cytokine production via the MAVS adaptor. During early infection, γHV68 hijacks MAVS and IKKβ to induce the site-specific phosphorylation of RelA, a crucial subunit of the transcriptionally active NFκB dimer, which primes RelA for the proteasome-mediated degradation. As such, γHV68 efficiently abrogated NFκB activation and cytokine gene expression. Conversely, uncoupling RelA degradation from γHV68 infection promoted NFκB activation and elevated cytokine production. Loss of MAVS increased cytokine production and immune cell infiltration in the lungs of γHV68-infected mice. Moreover, exogenous expression of the phosphorylation- and degradation-resistant RelA variant restored γHV68-induced cytokine production. Our findings uncover an intricate strategy whereby signaling via the upstream MAVS adaptor is intercepted by a pathogen to nullify the immediate downstream effector, RelA, of the innate immune pathway.
Vyšlo v časopise:
Murine Gamma Herpesvirus 68 Hijacks MAVS and IKKβ to Abrogate NFκB Activation and Antiviral Cytokine Production. PLoS Pathog 7(11): e32767. doi:10.1371/journal.ppat.1002336
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002336
Souhrn
Upon viral infection, mitochondrial antiviral signaling (MAVS) protein serves as a key adaptor to promote cytokine production. We report here that murine gamma herpesvirus 68 (γHV68), a model virus for oncogenic human gamma herpesviruses, subverts cytokine production via the MAVS adaptor. During early infection, γHV68 hijacks MAVS and IKKβ to induce the site-specific phosphorylation of RelA, a crucial subunit of the transcriptionally active NFκB dimer, which primes RelA for the proteasome-mediated degradation. As such, γHV68 efficiently abrogated NFκB activation and cytokine gene expression. Conversely, uncoupling RelA degradation from γHV68 infection promoted NFκB activation and elevated cytokine production. Loss of MAVS increased cytokine production and immune cell infiltration in the lungs of γHV68-infected mice. Moreover, exogenous expression of the phosphorylation- and degradation-resistant RelA variant restored γHV68-induced cytokine production. Our findings uncover an intricate strategy whereby signaling via the upstream MAVS adaptor is intercepted by a pathogen to nullify the immediate downstream effector, RelA, of the innate immune pathway.
Zdroje
1. AkiraSUematsuSTakeuchiO 2006 Pathogen recognition and innate immunity. Cell 124 783 801
2. MedzhitovR 2007 Recognition of microorganisms and activation of the immune response. Nature 449 819 826
3. RobinsonMJSanchoDSlackECLeibundGut-LandmannSReis e SousaC 2006 Myeloid C-type lectins in innate immunity. Nat Immunol 7 1258 1265
4. HornungVEllegastJKimSBrzózkaKJungA 2006 5′-Triphosphate RNA is the ligand for RIG-I. Science 314 994 997
5. PichlmairASchulzOTanCPNäslundTILiljeströmP 2006 RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314 997 1001
6. SethRBSunLEaCKChenZJ 2005 Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122 669 682
7. KawaiTTakahashiKSatoSCobanCKumarH 2005 IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6 981 988
8. XuLGWangYYHanKJLiLYZhaiZ 2005 VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19 727 740
9. MeylanECurranJHofmannKMoradpourDBinderM 2005 Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 1167 1172
10. ChenZJParentLManiatisT 1996 Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell 84 853 862
11. FitzgeraldKAMcWhirterSMFaiaKLRoweDCLatzE 2003 IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4 491 496
12. MercurioFZhuHMurrayBWShevchenkoABennettBL 1997 IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278 860 866
13. SharmaStenOeverBRGrandvauxNZhouGPLinR 2003 Triggering the interferon antiviral response through an IKK-related pathway. Science 300 1148 1151
14. PanneDManiatisTHarrisonSC 2007 An atomic model of the interferon-beta enhanceosome. Cell 129 1111 1123
15. ThanosDManiatisT 1995 Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83 1091 1100
16. SiebenlistUFranzosoGBrownK 1994 Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10 405 455
17. ChenLFGreeneWC 2004 Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5 392 401
18. PerkinsND 2006 Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 25 6717 6730
19. CoscoyL 2007 Immune evasion by Kaposi's sarcoma-associated herpesvirus. Nat Rev Immunol 7 391 401
20. SpeckSHGanemD 2010 Viral latency and its regulation: lessons from the gamma-herpesviruses. Cell Host Microbe 8 100 115
21. SpeckSHVirginHW 1999 Host and viral genetics of chronic infection: a mouse model of gamma-herpesvirus pathogenesis. Curr Opin Microbiol 2 403 409
22. DongXFengHSunQLiHWuTT 2010 Murine gamma-herpesvirus 68 hijacks MAVS and IKKbeta to initiate lytic replication. PLoS Pathog 6 e1001001
23. SunQSunLLiuHHChenXSethRB 2006 The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24 633 642
24. KumarHKawaiTKatoHSatoSTakahashiK 2006 Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med 203 1795 1803
25. BrownHJSongMJDengHWuTTChengG 2003 NF-kappaB inhibits gammaherpesvirus lytic replication. J Virol 77 8532 8540
26. SarawarSRBrooksJWCardinRDMehrpooyaMDohertyPC 1998 Pathogenesis of murine gammaherpesvirus-68 infection in interleukin-6-deficient mice. Virology 249 359 366
27. MoserBClark-LewisIZwahlenRBaggioliniM 1990 Neutrophil-activating properties of the melanoma growth-stimulatory activity. J Exp Med 171 1797 1802
28. SchallTJBaconKToyKJGoeddelDV 1990 Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347 669 671
29. SakuraiHChibaHMiyoshiHSugitaTToriumiW 1999 IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274 30353 30356
30. LawrenceTBebienMLiuGYNizetVKarinM 2005 IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature 434 1138 1143
31. SchwabeRFSakuraiH 2005 IKKßeta phosphorylates p65 at S468 in transactivaton domain 2. FASEB J 19 1758 1760
32. MaoXGluckNLiDMaineGNLiH 2009 GCN5 is a required cofactor for a ubiquitin ligase that targets NF-kappaB/RelA. Genes Dev 23 849 861
33. GengHWittwerTDittrich-BreiholzOKrachtMSchmitzML 2009 Phosphorylation of NF-kappaB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination. EMBO Rep 10 381 386
34. SutharMSMaDYThomasSLundJMZhangN 2010 IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog 6 e1000757
35. ChenZBenureauYRijnbrandRYiJWangT 2007 GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS. J Virol 81 964 976
36. LiXDSunLSethRBPinedaGChenZJ 2005 Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 102 17717 17722
37. LooYMOwenDMLiKEricksonAKJohnsonCL 2006 Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A 103 6001 6006
38. YangYLiangYQuLChenZYiM 2007 Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. (2007). Proc Natl Acad Sci U S A 104 7253 7258
39. BowieAGUnterholznerL 2008 Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol 8 911 922
40. DiacovichLGorvelJP 2010 Bacterial manipulation of innate immunity to promote infection. Nat Rev Microbiol 8 117 128
41. FoyELiKWangCSumpterRJrIkedaM 2003 Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300 1145 1148
42. SchröderMBaranMBowieAG 2008 Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. EMBO J 27 2147 2157
43. ChangTHKubotaTMatsuokaMJonesSBradfuteSB 2009 Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery. PLoS Pathog 5 e1000493
44. HwangSKimKSFlanoEWuTTTongLM 2010 Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response. Cell Host Microbe 5 166 178
45. NevesPLampropoulouVCalderon-GomezERochTStervboU 2010 Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 33 777 790
46. RoundJLLeeSMLiJTranGJabriB 2011 The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332 974 977
47. ArpaiaNGodecJLauLSivickKEMcLaughlinLM 2011 TLR signaling is required for Salmonella typhimurium virulence. Cell 144 675 688
48. KrugLTMoserJMDickersonSMSpeckSH 2007 Inhibition of NF-kappaB activation in vivo impairs establishment of gammaherpesvirus latency. PLoS Pathog 3 e11
49. ChenLFWilliamsSAMuYNakanoHDuerrJM 2005 NF-kappaB RelA phosphorylation regulates RelA acetylation. Mol Cell Biol 25 7966 7975
50. MaineGNMaoXKomarckCMBursteinE 2007 COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase. EMBO J 26 436 447
51. RyoASuizuFYoshidaYPerremKLiouYC 2003 Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol Cell 12 1413 1426
52. TanakaTGrusbyMJKaishoT 2007 PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit. Nat Immunol 8 584 591
53. RodriguesLFilipeJSeldonMPFonsecaLAnratherJ 2009 Termination of NF-kappaB activity through a gammaherpesvirus protein that assembles an EC5S ubiquitin-ligase. EMBO J 28 1283 1295
54. YuYWangSEHaywardGS 2005 The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 22 59 70
55. FengPLiangCShinYCXiaofeiEZhangW 2007 A novel inhibitory mechanism of mitochondrion-dependent apoptosis by a herpesviral protein. PLoS Pathog 3 e174
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 11
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Multiple Candidate Effectors from the Oomycete Pathogen Suppress Host Plant Immunity
- The Splicing Factor Proline-Glutamine Rich (SFPQ/PSF) Is Involved in Influenza Virus Transcription
- A TNF-Regulated Recombinatorial Macrophage Immune Receptor Implicated in Granuloma Formation in Tuberculosis
- SH3 Domain-Mediated Recruitment of Host Cell Amphiphysins by Alphavirus nsP3 Promotes Viral RNA Replication